journal article·2025-07

Convertible ROS Nanogenerator/Eliminator for Enhanced Tumor Photothermal Therapy with Reduced Inflammatory Response

Houren Zhou, Xinyu Zhang, Hui Liu, Yuan Gao, Mengyao Mu, Yiyong Tang, Tongxin Jiang, Zeran Zhang, Shangui Liu, Li Xian Yip, Xiao Sun, Zhijun Liu

Advanced Functional Materials· Volume 35· Issue 29
Publisher page

Abstract

Abstract Photothermal therapy (PTT), as an innovative optical tumor treatment strategy, is characterized by its minimal invasiveness, high selectivity, long‐lasting efficacy, and high safety, and has attracted widespread attention. However, in order to effectively kill cancer cells, a higher local temperature is very necessary, which inevitably results in severe stress responses and cell death, thereby triggering harmful inflammation. Additionally, achieving effective controlled release of drugs in the tumor microenvironment to reduce systemic side effects is still a major challenge. Herein, an intelligent nanoplatform is first reported, which featured sulfide iron (FeS) nanosheets as the core, loaded with perfluorohexane (PFH), and skillfully coated with polydopamine (PDA). It can serve as a generator of reactive oxygen species (ROS) in the tumor microenvironment to induce tumor cell ferroptosis, further intensifying PTT, and as a ROS eliminator in normal tissue to effectively control the undesired inflammatory response during PTT, achieving a differential treatment strategy between tumor and surrounding normal tissue. Meanwhile, the combination of ultrasound‐targeted microbubble destruction (UTMD) technology significantly enhanced the local penetration and release of the drug. Overall, systemic delivery of FeS/PFH@PDA combined UTMD can achieve precise and efficient synergistic therapy for tumors and demonstrate outstanding ultrasound and MR dual‐mode imaging performance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Gas Sensing Nanomaterials and Sensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Ultrasound Department Shengjing Hospital China Medical University Shenyang 110004 China

Ultrasound Department The Second Affiliated Hospital of Dalian Medical University Dalian 116023 China

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan 250117 China

Department of Chemical and Biomolecular Engineering National University of Singapore Singapore 117585 Singapore

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Taishan Scholar Foundation of Shandong Province

References (40)

Show source-provided references
1. 10.1016/j.actbio.2024.01.00710.1016/j.actbio.2024.01.007 ↗
2. 10.1016/j.bioactmat.2024.03.02410.1016/j.bioactmat.2024.03.024 ↗
3. 10.1002/EXP.2023016310.1002/EXP.20230163 ↗
4. 10.1016/j.biomaterials.2014.10.05210.1016/j.biomaterials.2014.10.052 ↗
5. 10.1126/sciadv.abb131110.1126/sciadv.abb1311 ↗
6. 10.1002/adma.20230008610.1002/adma.202300086 ↗
7. 10.1002/smll.20210707110.1002/smll.202107071 ↗
8. 10.1016/j.biomaterials.2022.12181510.1016/j.biomaterials.2022.121815 ↗
9. 10.1039/D3TB00839H10.1039/D3TB00839H ↗
10. 10.1002/adma.20200848110.1002/adma.202008481 ↗
11. 10.1016/j.mattod.2022.01.01910.1016/j.mattod.2022.01.019 ↗
12. 10.1021/acsnano.1c0561810.1021/acsnano.1c05618 ↗
13. 10.1002/anie.20170964810.1002/anie.201709648 ↗
14. 10.1002/adfm.20210129710.1002/adfm.202101297 ↗
15. 10.1039/C9NR06489C10.1039/C9NR06489C ↗
16. 10.1021/acsnano.6b0665110.1021/acsnano.6b06651 ↗
17. 10.1021/acsnano.1c0038010.1021/acsnano.1c00380 ↗
18. 10.1038/s41422-019-0164-510.1038/s41422-019-0164-5 ↗
19. 10.1016/j.redox.2020.10150010.1016/j.redox.2020.101500 ↗
20. 10.1002/anie.20180230910.1002/anie.201802309 ↗
21. 10.1016/j.apmt.2020.10092910.1016/j.apmt.2020.100929 ↗
22. 10.1002/anie.20220721310.1002/anie.202207213 ↗
23. 10.1021/acsnano.3c1024910.1021/acsnano.3c10249 ↗
24. 10.1002/adhm.20230448510.1002/adhm.202304485 ↗
25. 10.1002/anie.20211292510.1002/anie.202112925 ↗
26. 10.1016/j.redox.2020.10156410.1016/j.redox.2020.101564 ↗
27. 10.1016/j.redox.2020.10177210.1016/j.redox.2020.101772 ↗
28. 10.1016/j.jconrel.2022.04.00610.1016/j.jconrel.2022.04.006 ↗
29. 10.1186/s12951-024-02453-010.1186/s12951-024-02453-0 ↗
30. 10.1080/10717544.2021.195504110.1080/10717544.2021.1955041 ↗
31. 10.1021/acs.nanolett.3c0371910.1021/acs.nanolett.3c03719 ↗
32. 10.1002/advs.20240118210.1002/advs.202401182 ↗
33. 10.2147/DDDT.S35162310.2147/DDDT.S351623 ↗
34. 10.1186/s12951-023-02204-710.1186/s12951-023-02204-7 ↗
35. 10.1021/jacs.2c1322210.1021/jacs.2c13222 ↗
36. 10.1016/j.actbio.2022.07.04610.1016/j.actbio.2022.07.046 ↗
37. 10.1016/j.cej.2020.12529410.1016/j.cej.2020.125294 ↗
38. 10.1021/acs.est.3c1063710.1021/acs.est.3c10637 ↗
39. 10.1002/smll.20231070610.1002/smll.202310706 ↗
40. 10.1002/advs.20230369410.1002/advs.202303694 ↗